宁波美诺华药业股份有限公司 关于回购股份注销完成暨持股5%以上股东权益 被动变动触及1%整数倍的提示性公告

Core Viewpoint - The company, Ningbo Meinuo Pharmaceutical Co., Ltd., has completed the repurchase and cancellation of part of the restricted stock incentive plan, resulting in a slight increase in the shareholding percentage of its controlling shareholder, Ningbo Meinuo Holding Group Co., Ltd., and its actual controller, Yao Chengzhi, without changing the overall control structure of the company [3][4][5]. Group 1: Share Repurchase and Cancellation - The company has repurchased and canceled 181,100 shares from the 2024 restricted stock incentive plan, confirmed by the China Securities Depository and Clearing Corporation Shanghai Branch [3][5]. - Following the cancellation, the total share capital of the company decreased from 220,631,264 shares to 220,450,164 shares [3][4]. - The shareholding percentage of the controlling shareholder increased from 25.9963% to 26.0176% due to the reduction in total share capital, although the number of shares held remained unchanged [4][5]. Group 2: Regulatory Compliance and Disclosure - The company has adhered to the relevant regulations set forth by the China Securities Regulatory Commission regarding the disclosure of equity changes when the shareholding percentage reaches 1% increments [5]. - The equity change resulting from the share repurchase does not lead to any changes in the company's controlling shareholder or actual controller, nor does it significantly impact the company's governance structure or ongoing operations [5].